AG
DGX icon

AIA Group’s Quest Diagnostics DGX Stock Holding History

AIA Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.87M Sell
50,374
-4,777
-9% -$928K 0.14% 100
2025
Q4 		$9.57M Buy
55,151
+51,911
+1,602% +$9.45M 0.14% 102
2025
Q3 		$617K Buy
+3,240
New +$575K 0.01% 334
2023
Q2 		– Sell
-2,784
Closed -$394K – 369
2023
Q1 		$394K Sell
2,784
-454
-14% -$65K 0.02% 252
2022
Q4 		$507K Buy
3,238
+703
+28% +$101K 0.03% 220
2022
Q3 		$311K Sell
2,535
-1,562
-38% -$206K 0.02% 244
2022
Q2 		$545K Buy
4,097
+1,978
+93% +$270K 0.03% 222
2022
Q1 		$290K Sell
2,119
-4,844
-70% -$675K 0.01% 301
2021
Q4 		$1.21M Buy
+6,963
New +$1.06M 0.06% 124

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

AIA Group's DGX Position: Q1 2026 in Review

AIA Group reduced its Quest Diagnostics (DGX) stake by 8.7% in Q1 2026, selling an estimated $928K and leaving 50,374 shares worth $9.87M. The position accounts for 0.14% of the portfolio, ranked #100.

AIA Group first reported a position in DGX in Q4 2021 and has held it in 9 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • AIA Group held 50,374 shares of Quest Diagnostics worth $9.87M as of Q1 2026.
  • AIA Group sold 4,777 Quest Diagnostics shares in Q1 2026, an estimated $928K.
  • Quest Diagnostics made up 0.14% of AIA Group's portfolio in Q1 2026, its #100 holding.
  • AIA Group first reported a position in Quest Diagnostics in Q4 2021 and has held it in 9 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.